Peijia Medical (FRA:4WO) EBIT : €-31.87 Mil (TTM As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Peijia Medical EBIT?

Peijia Medical's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was €-8.75 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was €-31.87 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Peijia Medical's annualized ROC % for the quarter that ended in Jun. 2024 was -11.37%. Peijia Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -21.35%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Peijia Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -13.14%.

Peijia Medical EBIT Historical Data

The historical data trend for Peijia Medical's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peijia Medical EBIT Chart

Peijia Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-68.16

-260.02

-79.76

-53.61

-50.26

Peijia Medical Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT	Get a 7-Day Free Trial							-12.81	-41.33	-27.24	-23.12	-8.75

Competitive Comparison of Peijia Medical's EBIT

For the Medical Devices subindustry, Peijia Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Peijia Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Peijia Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Peijia Medical's EV-to-EBIT falls into.

Peijia Medical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-31.87 Mil.

Peijia Medical (FRA:4WO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Peijia Medical's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

	ROC % (Q: Jun. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Jun. 2024 ))	/ count )
=	-21.99 * ( 1 - -4.09% )	/	( (204.354	+	198.189)	/ 2 )
=	-22.889391	/	201.2715
=	-11.37 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	343.154	-	17.702	-	( 121.098	-	max(0, 19.81	-	158.928	+	121.098	))
=	204.354

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	334.732	-	18.054	-	( 118.489	-	max(0, 22.337	-	156.575	+	118.489	))
=	198.189

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Peijia Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Jun. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-17.504	/	( ( (58.824 + max(20.128, 0))	+	(65 + max(19.997, 0)) )	/	2 )
=	-17.504	/	( ( 78.952	+	84.997 )	/	2 )
=	-17.504	/	81.9745
=	-21.35 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(10.301	+	21.916	+	5.613)	-	(17.702	+	0	+	-3.5527136788005E-15)
=	20.128

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(13.072	+	20.125	+	4.889)	-	(18.054	+	0	+	0.035)
=	19.997

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Peijia Medical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2024 )
	=	-31.867	/	242.447
	=	-13.14 %

Peijia Medical EBIT Related Terms

Thank you for viewing the detailed overview of Peijia Medical's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Peijia Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Peijia Medical Ltd (FRA:4WO) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

09996:Hong Kong

Address

8 Zhongtian Street, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN

Website

https://www.peijiamedical.com

Peijia Medical Ltd is focused on the interventional procedural, transcatheter valve therapeutic, and the neurointerventional procedural medical device market in China. The company's product candidates include Transcatheter Aortic Valve Replacement products, Transcatheter Mitral Valve Replacement/Transcatheter Tricuspid Valve Replacement products, Ancillary products, Neurointerventional products, and its product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates. Its operating segments are Transcatheter Valve Therapeutic Business and Neurointerventional Business.

Peijia Medical Headlines

No Headlines